Cargando…
Investigating the landscape of US orphan product approvals
BACKGROUND: The Orphan Drug Act was enacted in 1983 to encourage the development of drugs for rare diseases. Previous research has attempted to examine the impact of the Act by assessing either the number of orphan designations that have been granted or the number of new orphan drugs approved for ma...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198498/ https://www.ncbi.nlm.nih.gov/pubmed/30348193 http://dx.doi.org/10.1186/s13023-018-0930-3 |